Literature DB >> 28288285

Reply: The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps.

Francis X McCormack1, Nishant Gupta1, Geraldine R Finlay2, Lisa R Young3, Simon R Johnson4, Vincent Cottin5, Kevin C Wilson6, Joel Moss7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28288285      PMCID： PMC5803663          DOI： 10.1164/rccm.201702-0417LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis.

Authors:  Lisa R Young; Yoshikazu Inoue; Francis X McCormack
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

2.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Authors:  S R Johnson; J F Cordier; R Lazor; V Cottin; U Costabel; S Harari; M Reynaud-Gaubert; A Boehler; M Brauner; H Popper; F Bonetti; C Kingswood
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

3.  Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.

Authors:  Lisa R Young; Rhonda Vandyke; Peter M Gulleman; Yoshikazu Inoue; Kevin K Brown; Laura S Schmidt; W Marston Linehan; Fuad Hajjar; Brent W Kinder; Bruce C Trapnell; John J Bissler; David N Franz; Francis X McCormack
Journal:  Chest       Date:  2010-04-09       Impact factor: 9.410

4.  The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Authors:  Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo Taveira-Dasilva; Francis X McCormack; Nilo A Avila; Rosamma M Decastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

5.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

6.  Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  John J Bissler; J Christopher Kingswood; Elżbieta Radzikowska; Bernard A Zonnenberg; Michael Frost; Elena Belousova; Matthias Sauter; Norio Nonomura; Susanne Brakemeier; Petrus J de Vries; Vicky H Whittemore; David Chen; Tarek Sahmoud; Gaurav Shah; Jeremie Lincy; David Lebwohl; Klemens Budde
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

7.  Role of serum vascular endothelial growth factor D in discrimination of patients with polycystic lung diseases.

Authors:  Elżbieta Radzikowska; Paulina Jaguś; Agnieszka Skoczylas; Małgorzata Sobiecka; Joanna Chorostowska-Wynimko; Elżbieta Wiatr; Jan Kuś; Kazimierz Roszkowski-Śliż
Journal:  Pol Arch Med Wewn       Date:  2013-09-24

8.  Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis.

Authors:  William Y C Chang; Jennifer L Cane; John D Blakey; Maruti Kumaran; Kate S Pointon; Simon R Johnson
Journal:  Respir Res       Date:  2012-04-18

9.  Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.

Authors:  Sandra L Dabora; David Neal Franz; Stephen Ashwal; Arthur Sagalowsky; Francis J DiMario; Daniel Miles; Drew Cutler; Darcy Krueger; Raul N Uppot; Rahmin Rabenou; Susana Camposano; Jan Paolini; Fiona Fennessy; Nancy Lee; Chelsey Woodrum; Judith Manola; Judy Garber; Elizabeth A Thiele
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

10.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.